Pendi Tablet (Phemtemetri Pen Tartaric Acid)

Adult dose

As Phemtemetri Pen Tartaric Acid, an oral dose of 35 mg is administered 2 to 3 times a day, 1 hour before meals. The dosage should utilize the minimum effective dose but adjusted individually. For some patients, a dosage of 17.5 mg once daily may be appropriate. The dosage should not exceed 70 mg at a time or be taken more than 3 times a day. This medication is to be administered short-term (within 4 weeks), with satisfactory weight loss expected within the first 4 weeks.

This medication should only be used alone for a short period, as using it with other appetite suppressants can cause serious heart problems. Long-term use of this medication may significantly increase the risk of a rare heart disease called pulmonary hypertension, and if symptoms such as shortness of breath, chest pain, fainting, or leg swelling occur, the medication should be stopped immediately, and the patient should seek medical attention. As this medication may also be associated with heart valve disease, it is advisable to check heart conditions before administration; those with existing heart disease should refrain from using this medication. This medication should not be used in patients with certain diseases or conditions, such as cardiovascular disease, hypertension, hyperthyroidism, glaucoma, mental instability, or a history of substance abuse. Additionally, children under 16 years of age, pregnant women or women who may become pregnant, and certain genetically predisposed lactose intolerant patients should not take this medication. Patients with mild hypertension or diabetes, and nursing mothers should use this medication with caution, and adjustments in insulin dosage may be necessary for diabetic patients. This medication can cause various side effects such as increased heart rate, elevated blood pressure, anxiety, insomnia, dizziness, dry mouth, dyspepsia, changes in sexual function, etc., so any abnormal symptoms should prompt consultation with a physician. During the use of this medication, caution is advised when driving or operating hazardous machinery, and if the appetite-suppressing effect diminishes, the dosage should not be increased but should be stopped. In the case of overdose, severe symptoms such as anxiety, coma, seizures, abnormal blood pressure, and vomiting may occur, requiring immediate emergency treatment. This medication should be kept out of reach of children and should be used strictly according to a physician's prescription and guidance, as there is potential for drug abuse and dependence. It is advisable for pregnant or nursing women to avoid using this medication and to refrain from taking it if planning for pregnancy.

Serious side effects

• Rash
• peripheral edema
• exercise-induced dyspnea
• angina symptoms
• fainting
• pulmonary hypertension
• mental disorders
• extreme fatigue
• depression
• coma

Mild side effects

• Palpitations
• tachycardia
• increased blood pressure
• overstimulation
• anxiety
• dizziness
• insomnia
• tremors
• euphoria
• headache

This medication must be stored in a tightly closed container to protect it from air and moisture and should be kept at room temperature, between 1 degree and 30 degrees Celsius. Proper storage ensures the maintenance of the medication’s efficacy and safety.

Appearance

White to whitish round tablets

Package unit

30 tablets/box [(10 tablets/PTP x3)], 300 tablets/bottle